Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TDP1 | Q9NUW8 | 11/20 | 0.70 |
| ▸ | KDM4E | B2RXH2 | 10/20 | 0.70 |
| ▸ | HSD17B10 | Q99714 | 8/20 | 0.70 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.70 |
| ▸ | HPGD | P15428 | 4/20 | 0.70 |
| ▸ | KMT2A | Q03164 | 4/20 | 0.70 |
| ▸ | GRM1 | Q13255 | 3/20 | 0.70 |
| ▸ | MEN1 | O00255 | 3/20 | 0.70 |
| ▸ | CYP2C9 | P11712 | 3/20 | 0.70 |
| ▸ | GRM2 | Q14416 | 2/20 | 0.70 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.70 |
| ▸ | BLM | P54132 | 4/20 | 0.65 |
| ▸ | LMNA | P02545 | 4/20 | 0.65 |
| ▸ | PTGS1 | P23219 | 2/20 | 0.65 |
| ▸ | NR1I2 | O75469 | 1/20 | 0.65 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.65 |
| ▸ | SLC6A2 | P23975 | 2/20 | 0.58 |
| ▸ | DRD3 | P35462 | 2/20 | 0.58 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.58 |
| ▸ | GRM8 | O00222 | 1/20 | 0.58 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10723439 | 1.00 | TDP1 (0.70) | TDP1KDM4EHSD17B10ALDH1A1HPGD | |
| SCHEMBL3478437 | 1.00 | TDP1 (0.70) | TDP1KDM4EHSD17B10ALDH1A1HPGD | |
| Bromide SCHEMBL11670638 | 0.98 | TDP1 (0.68) | TDP1KDM4EHSD17B10ALDH1A1HPGD | |
| SCHEMBL10721569 | 0.83 | TDP1 (0.55) | TDP1KDM4EHSD17B10ALDH1A1HPGD | |
| SCHEMBL11926758 | 0.83 | TDP1 (0.55) | TDP1KDM4EHSD17B10ALDH1A1HPGD | |
| SCHEMBL12648648 | 0.82 | HSD17B10 (1.00) | TDP1KDM4EHSD17B10ALDH1A1HPGD | |
| SCHEMBL20522819 | 0.82 | HSD17B10 (0.64) | TDP1KDM4EHSD17B10ALDH1A1HPGD | |
| SCHEMBL20693801 | 0.82 | HSD17B10 (0.64) | TDP1KDM4EHSD17B10ALDH1A1HPGD | |
| SCHEMBL20522818 | 0.82 | HSD17B10 (0.64) | TDP1KDM4EHSD17B10ALDH1A1HPGD | |
| SCHEMBL11396129 | 0.82 | HSD17B10 (0.64) | TDP1KDM4EHSD17B10ALDH1A1HPGD |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 192 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240408041-A1 | COMPOSITIONS AND METHODS FOR TREATING CANNABINOID HYPEREMESIS SYNDROME | HABBOUSHE JOSEPH (US) | 2024-12-12 | — | — | US | claimed |
| EP-4237427-A1 | ANTIBACTERIAL CYCLOPEPTIDES TARGETING ACINETOBACTER AND OTHER GRAM-NEGATIVE PATHOGENS | University of Utah Research Foundation (US) | 2023-09-06 | — | — | EP | claimed |
| CN-116670151-A | Antibacterial cyclic peptides targeting acinetobacter and other gram negative pathogens | 犹他大学研究基金会 | 2023-08-29 | — | — | CN | claimed |
| WO-2022094273-A1 | ANTIBACTERIAL CYCLOPEPTIDES TARGETING ACINETOBACTER AND OTHER GRAM-NEGATIVE PATHOGENS | UNIVERSITY OF UTAH RESEARCH FOUNDATION (US) | 2022-05-05 | — | — | WO | claimed |
| WO-2021140526-A1 | MUTANT PENICILLIN G ACYLASES OF ACHROMOBACTER CCM4824 | FERMENTA BIOTECH LIMITED (IN) | 2021-07-15 | — | — | WO | claimed |
| CN-107523219-B | Chemical Mechanical Polishing (CMP) of cobalt-containing substrates | 弗萨姆材料美国有限责任公司 | 2020-12-29 | — | — | CN | claimed |
| US-10745589-B2 | Chemical mechanical polishing (CMP) of cobalt-containing substrate | VERSUM MATERIALS US, LLC (US) | 2020-08-18 | — | — | US | claimed |
| US-20200061155-A1 | COMPOSITIONS AND METHODS FOR TREATING LYNX2 DISORDERS | OPHIDION INC. | 2020-02-27 | — | — | US | claimed |
| US-20190172720-A1 | Chemical Mechanical Polishing (CMP) of Cobalt-Containing Substrate | VERSUM MATERIALS US, LLC (US) | 2019-06-06 | — | — | US | claimed |
| EP-3257910-B1 | CHEMICAL MECHANICAL POLISHING (CMP) COMPOSITION, METHOD AND SYSTEM FOR COBALT-CONTAINING SUBSTRATE | VERSUM MAT US LLC (US) | 2019-03-27 | — | — | EP | claimed |
| EP-2604697-B1 | Triprenyl phenol compounds, process for their production and use as thrombolysis enhancer | UNIV TOKYO AGRICULTURE & TECHNOLOGY TLO CO LTD (JP) | 2015-07-01 | — | — | EP | claimed |
| EP-2344151-A2 | TREATMENT AND/OR PREVENTION OF INNER EAR CONDITIONS BY MODULATION OF A METABOTROPIC GLUTAMATE RECEPTOR | HOUSE EAR INSTITUTE (US) | 2011-07-20 | — | — | EP | claimed |
| WO-2010048095-A2 | TREATMENT AND/OR PREVENTION OF INNER EAR CONDITIONS BY MODULATION OF A METABOTROPIC GLUTAMATE RECEPTOR | HOUSE EAR INSTITUTE (US) | 2010-04-29 | — | — | WO | claimed |
| US-7309719-B1 | Storage stability; gabapentin and pregabalin, and neutral alpha -amino acid | WARNER LAMBERT COMPANY, LLC (US) | 2007-12-18 | — | — | US | claimed |
| EP-1077692-B1 | AMINO ACID STABILIZED GABAPENTIN AND PREGABALIN PREPARATIONS AND PROCESS FOR PREPARING THE SAME | WARNER LAMBERT CO (US) | 2004-07-28 | — | — | EP | claimed |
| EP-0848064-B1 | New antibiotic, Feglymycine, process for its preparation and use of the same | HOECHST AG (DE) | 2001-11-14 | — | — | EP | claimed |
| EP-1077692-A1 | AMINO ACID STABILIZED GABAPENTIN AND PREGABALIN PREPARATIONS AND PROCESS FOR PREPARING THE SAME | Warner-Lambert Company LLC (US) | 2001-02-28 | — | — | EP | claimed |
| WO-1999059573-A9 | STABILIZED PHARMACEUTICAL PREPARATIONS OF GAMMA-AMINOBUTYRIC ACID DERIVATIVES AND PROCESS FOR PREPARING THE SAME | WARNER LAMBERT CO (US) | 2000-05-04 | — | — | WO | claimed |
| WO-1999059573-A1 | STABILIZED PHARMACEUTICAL PREPARATIONS OF GAMMA-AMINOBUTYRIC ACID DERIVATIVES AND PROCESS FOR PREPARING THE SAME | WARNER-LAMBERT COMPANY (US) | 1999-11-25 | — | — | WO | claimed |
| EP-0164026-A1 | Process for the preparation of optically active glycine derivatives | BEECHAM GROUP PLC (GB) | 1985-12-11 | — | — | EP | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240408041-A1 | COMPOSITIONS AND METHODS FOR TREATING CANNABINOID HYPEREMESIS SYNDROME | CNR2, TRPV1, CNR1 | TDP1 2408/4885KDM4E 3214/4885HSD17B10 3191/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.